A Double-Masked, Randomized, Controlled Study of the Safety, Tolerability and Biological Effect of Repeated Intravitreal Administration of VEGF Trap-Eye in Patients With Diabetic Macular Edema (DME).
Phase of Trial: Phase II
Latest Information Update: 30 Oct 2014
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms DA VINCI
- Sponsors Regeneron Pharmaceuticals
- 01 Aug 2012 1-Year results published in the Ophthalmology.
- 25 Jan 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 25 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History